Molecular Transport Medium Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Report
336 Pages
December 2023
Region: Global
Fairfield Market Research
ID: 5916020

The global molecular transport medium market, which recorded revenues of US$ 1.6 billion in 2021, experienced a temporary dip but is now poised for steady growth. Projections indicate the market reaching US$ 1.2 billion by 2031.

Fueling Growth for Molecular Transport Medium Manufacturers

Innovative Technology - Revolutionizing Viral Transport Mediums

Technological advancements have led to a shift from traditional transport mediums to innovative molecular transport mediums, offering enhanced safety and convenience. These new products reduce exposure risks with non-hazardous and leak-proof formulations for transport, storage, and processing.

Preserving sample stability during transport and storage is another critical driver, as rapid storage is vital to prevent degradation or cell death after sample collection. Molecular transport mediums play a crucial role in maintaining sample stability during storage and transportation for approximately 48 hours, avoiding the need for freezing and thawing.

Challenges to Market Expansion

Presence of Alternative Technologies

Alternative solutions for stabilizing specimens, particularly for virus, bacteria, and fungus detection, pose a challenge to the molecular transport medium market. These solutions often use saline or buffered salt solutions to maintain a neutral pH. Researchers are exploring plant-based protein supplements to enhance virus stability.

Seasonal infections and the unpredictability of disease outbreaks affect demand for molecular transport mediums. Public awareness campaigns have increased testing rates, but demand may still outstrip supply due to the sporadic nature of infections.

Shelf-life limitations also hinder market growth, as molecular transport mediums have a short storage duration.

Country-wise Insights

U.S. Market: A Lucrative Opportunity

High awareness of disease prevention benefits, the presence of key players, and increased healthcare expenditure drive the demand for molecular transport mediums in the U.S.

Germany Market: Riding the Wave of Innovation

The launch of novel viral transport mediums, such as Thermo Fisher Scientific Inc.'s InhibiSURE, has boosted sales in European countries, including Germany, by ensuring rapid inactivation of the COVID-19 virus during collection and transport.

China Market: Government Investment

Major government investments have prompted manufacturers to increase production capacity to meet surging demand for comprehensive testing of symptomatic and asymptomatic patients, driven by COVID-19 and other infectious diseases.

India Market: Focus on Genetic Research

India's focus on genetic research and innovative product development for biological sample storage and transport, exemplified by Azooka Labs' mWRAPR, has fueled market growth. mWRAPR, India's first local biological storage and transport medium, has garnered support from institutions like Honeywell and Citigroup.

Competitive Landscape

Leading market players are expanding their production capacities to meet high demand during peak periods and offering competitive pricing. They are also developing advanced products to attract more end-users and increase market share.

Key Companies Profiled

Thermo Fisher Scientific Inc.
Becton, Dickinson, and Company
Cardinal Health
Quidel Corporation
Medical Wire & Equipment
COPAN Diagnostics Inc.
Titan Biotech Ltd.
Alpha Teknova, Inc. (formerly named Teknova)
Bio-Genex Laboratories Inc.
EKF Diagnostics
Trinity Biotech
Alpha-Tec Systems, Inc.
Charm Sciences, Inc.
Azer Scientific
bioBoaVista
AccuGene
KSL Diagnostics
Puritan Medical Products
Amazing Biotech (Shanghai) Co., Ltd.

Key Segments Covered in Molecular Transport Medium Industry Research

Molecular Transport Medium Market by Product Type:

Active Transport Medium
Inactivated Transport Medium

Molecular Transport Medium Market by Application:

Virus
COVID-19
Middle East Respiratory Syndrome (MERS)
Influenza
Human Immunodeficiency Virus (HIV)
Rhinovirus
Adenovirus
Respiratory Syncytial Virus (RSV)
Bacteria
Staphylococcus Pneumonia
Haemophilus Influenza
Anthrax
Others
Atypical Bacteria
Mycoplasma
Q-Fever
Others
Mycobacterial and Fungal Infection

Molecular Transport Medium Market by Sample:

Nasal Washes and Swabs
Sputum
Saliva
Faecal & Stool
Urine
Blood
Tissues
Others

Molecular Transport Medium Market by End User:

Diagnostic Laboratories
Microbiology Laboratories
Hospitals & Clinics
Others

Molecular Transport Medium Market by Region:

North America Molecular Transport Medium Market
Latin America Molecular Transport Medium Market
Europe Molecular Transport Medium Market
South Asia Molecular Transport Medium Market
East Asia Molecular Transport Medium Market
Oceania Molecular Transport Medium Market
The Middle East & Africa Molecular Transport Medium Market

This product will be delivered within 1-3 business days.

1. Executive Summary

1.1. Global Molecular Transport Medium Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Molecular Transport Medium Market Outlook, 2018 - 2031

3.1. Global Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Active Transport Medium
3.1.1.2. Inactivated Transport Medium
3.2. Global Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Virus
3.2.1.1.1. COVID-19
3.2.1.1.2. Middle East Respiratory Syndrome (MERS)
3.2.1.1.3. Influenza
3.2.1.1.4. Human Immunodeficiency Virus (HIV)
3.2.1.1.5. Rhinovirus
3.2.1.1.6. Adenovirus
3.2.1.1.7. Respiratory Syncytial Virus (RSV)
3.2.1.2. Bacteria
3.2.1.2.1. Staphylococcus Pneumonia
3.2.1.2.2. Haemophilus Influenza
3.2.1.2.3. Anthrax
3.2.1.2.4. Others
3.2.1.3. Atypical Bacteria
3.2.1.3.1. Mycoplasma
3.2.1.3.2. Q-Fever
3.2.1.3.3. Others
3.2.1.4. Mycobacterial and Fungal Infection
3.3. Global Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Nasal Washes and Swabs
3.3.1.2. Sputum
3.3.1.3. Saliva
3.3.1.4. Faecal & Stool
3.3.1.5. Urine
3.3.1.6. Blood
3.3.1.7. Tissues
3.3.1.8. Others
3.4. Global Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Diagnostic Laboratories
3.4.1.2. Microbiology Laboratories
3.4.1.3. Hospitals & Clinics
3.4.1.4. Others
3.5. Global Molecular Transport Medium Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa

4. North America Molecular Transport Medium Market Outlook, 2018 - 2031

4.1. North America Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Active Transport Medium
4.1.1.2. Inactivated Transport Medium
4.2. North America Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Virus
4.2.1.1.1. COVID-19
4.2.1.1.2. Middle East Respiratory Syndrome (MERS)
4.2.1.1.3. Influenza
4.2.1.1.4. Human Immunodeficiency Virus (HIV)
4.2.1.1.5. Rhinovirus
4.2.1.1.6. Adenovirus
4.2.1.1.7. Respiratory Syncytial Virus (RSV)
4.2.1.2. Bacteria
4.2.1.2.1. Staphylococcus Pneumonia
4.2.1.2.2. Haemophilus Influenza
4.2.1.2.3. Anthrax
4.2.1.2.4. Others
4.2.1.3. Atypical Bacteria
4.2.1.3.1. Mycoplasma
4.2.1.3.2. Q-Fever
4.2.1.3.3. Others
4.2.1.4. Mycobacterial and Fungal Infection
4.3. North America Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Nasal Washes and Swabs
4.3.1.2. Sputum
4.3.1.3. Saliva
4.3.1.4. Faecal & Stool
4.3.1.5. Urine
4.3.1.6. Blood
4.3.1.7. Tissues
4.3.1.8. Others
4.4. North America Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Diagnostic Laboratories
4.4.1.2. Microbiology Laboratories
4.4.1.3. Hospitals & Clinics
4.4.1.4. Others
4.5. North America Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
4.5.1.2. U.S. Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
4.5.1.3. U.S. Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
4.5.1.4. U.S. Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
4.5.1.5. Canada Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
4.5.1.6. Canada Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
4.5.1.7. Canada Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
4.5.1.8. Canada Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Molecular Transport Medium Market Outlook, 2018 - 2031

5.1. Europe Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Active Transport Medium
5.1.1.2. Inactivated Transport Medium
5.2. Europe Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Virus
5.2.1.1.1. COVID-19
5.2.1.1.2. Middle East Respiratory Syndrome (MERS)
5.2.1.1.3. Influenza
5.2.1.1.4. Human Immunodeficiency Virus (HIV)
5.2.1.1.5. Rhinovirus
5.2.1.1.6. Adenovirus
5.2.1.1.7. Respiratory Syncytial Virus (RSV)
5.2.1.2. Bacteria
5.2.1.2.1. Staphylococcus Pneumonia
5.2.1.2.2. Haemophilus Influenza
5.2.1.2.3. Anthrax
5.2.1.2.4. Others
5.2.1.3. Atypical Bacteria
5.2.1.3.1. Mycoplasma
5.2.1.3.2. Q-Fever
5.2.1.3.3. Others
5.2.1.4. Mycobacterial and Fungal Infection
5.3. Europe Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Nasal Washes and Swabs
5.3.1.2. Sputum
5.3.1.3. Saliva
5.3.1.4. Faecal & Stool
5.3.1.5. Urine
5.3.1.6. Blood
5.3.1.7. Tissues
5.3.1.8. Others
5.4. Europe Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Diagnostic Laboratories
5.4.1.2. Microbiology Laboratories
5.4.1.3. Hospitals & Clinics
5.4.1.4. Others
5.5. Europe Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Germany Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.2. Germany Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
5.5.1.3. Germany Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
5.5.1.4. Germany Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
5.5.1.5. U.K. Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.6. U.K. Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
5.5.1.7. U.K. Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
5.5.1.8. U.K. Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
5.5.1.9. France Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.10. France Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
5.5.1.11. France Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
5.5.1.12. France Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
5.5.1.13. Italy Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.14. Italy Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
5.5.1.15. Italy Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
5.5.1.16. Italy Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
5.5.1.17. Turkey Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.18. Turkey Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
5.5.1.19. Turkey Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
5.5.1.20. Turkey Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
5.5.1.21. Russia Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.22. Russia Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
5.5.1.23. Russia Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
5.5.1.24. Russia Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
5.5.1.25. Rest of Europe Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
5.5.1.26. Rest of Europe Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
5.5.1.27. Rest of Europe Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
5.5.1.28. Rest of Europe Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Molecular Transport Medium Market Outlook, 2018 - 2031

6.1. Asia Pacific Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Active Transport Medium
6.1.1.2. Inactivated Transport Medium
6.2. Asia Pacific Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Virus
6.2.1.1.1. COVID-19
6.2.1.1.2. Middle East Respiratory Syndrome (MERS)
6.2.1.1.3. Influenza
6.2.1.1.4. Human Immunodeficiency Virus (HIV)
6.2.1.1.5. Rhinovirus
6.2.1.1.6. Adenovirus
6.2.1.1.7. Respiratory Syncytial Virus (RSV)
6.2.1.2. Bacteria
6.2.1.2.1. Staphylococcus Pneumonia
6.2.1.2.2. Haemophilus Influenza
6.2.1.2.3. Anthrax
6.2.1.2.4. Others
6.2.1.3. Atypical Bacteria
6.2.1.3.1. Mycoplasma
6.2.1.3.2. Q-Fever
6.2.1.3.3. Others
6.2.1.4. Mycobacterial and Fungal Infection
6.3. Asia Pacific Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Nasal Washes and Swabs
6.3.1.2. Sputum
6.3.1.3. Saliva
6.3.1.4. Faecal & Stool
6.3.1.5. Urine
6.3.1.6. Blood
6.3.1.7. Tissues
6.3.1.8. Others
6.4. Asia Pacific Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Diagnostic Laboratories
6.4.1.2. Microbiology Laboratories
6.4.1.3. Hospitals & Clinics
6.4.1.4. Others
6.5. Asia Pacific Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. China Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.2. China Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
6.5.1.3. China Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
6.5.1.4. China Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
6.5.1.5. Japan Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.6. Japan Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
6.5.1.7. Japan Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
6.5.1.8. Japan Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
6.5.1.9. South Korea Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.10. South Korea Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
6.5.1.11. South Korea Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
6.5.1.12. South Korea Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
6.5.1.13. India Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.14. India Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
6.5.1.15. India Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
6.5.1.16. India Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
6.5.1.17. Southeast Asia Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.18. Southeast Asia Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
6.5.1.19. Southeast Asia Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
6.5.1.20. Southeast Asia Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
6.5.1.21. Rest of Asia Pacific Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
6.5.1.22. Rest of Asia Pacific Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
6.5.1.23. Rest of Asia Pacific Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
6.5.1.24. Rest of Asia Pacific Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Molecular Transport Medium Market Outlook, 2018 - 2031

7.1. Latin America Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Active Transport Medium
7.1.1.2. Inactivated Transport Medium
7.2. Latin America Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
7.2.1.1. Virus
7.2.1.1.1. COVID-19
7.2.1.1.2. Middle East Respiratory Syndrome (MERS)
7.2.1.1.3. Influenza
7.2.1.1.4. Human Immunodeficiency Virus (HIV)
7.2.1.1.5. Rhinovirus
7.2.1.1.6. Adenovirus
7.2.1.1.7. Respiratory Syncytial Virus (RSV)
7.2.1.2. Bacteria
7.2.1.2.1. Staphylococcus Pneumonia
7.2.1.2.2. Haemophilus Influenza
7.2.1.2.3. Anthrax
7.2.1.2.4. Others
7.2.1.3. Atypical Bacteria
7.2.1.3.1. Mycoplasma
7.2.1.3.2. Q-Fever
7.2.1.3.3. Others
7.2.1.4. Mycobacterial and Fungal Infection
7.3. Latin America Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Nasal Washes and Swabs
7.3.1.2. Sputum
7.3.1.3. Saliva
7.3.1.4. Faecal & Stool
7.3.1.5. Urine
7.3.1.6. Blood
7.3.1.7. Tissues
7.3.1.8. Others
7.4. Latin America Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Diagnostic Laboratories
7.4.1.2. Microbiology Laboratories
7.4.1.3. Hospitals & Clinics
7.4.1.4. Others
7.5. Latin America Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Brazil Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
7.5.1.2. Brazil Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
7.5.1.3. Brazil Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
7.5.1.4. Brazil Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
7.5.1.5. Mexico Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
7.5.1.6. Mexico Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
7.5.1.7. Mexico Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
7.5.1.8. Mexico Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
7.5.1.9. Argentina Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
7.5.1.10. Argentina Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
7.5.1.11. Argentina Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
7.5.1.12. Argentina Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
7.5.1.13. Rest of Latin America Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
7.5.1.14. Rest of Latin America Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
7.5.1.15. Rest of Latin America Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
7.5.1.16. Rest of Latin America Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Molecular Transport Medium Market Outlook, 2018 - 2031

8.1. Middle East & Africa Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Active Transport Medium
8.1.1.2. Inactivated Transport Medium
8.2. Middle East & Africa Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. v
8.3. Middle East & Africa Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Nasal Washes and Swabs
8.3.1.2. Sputum
8.3.1.3. Saliva
8.3.1.4. Faecal & Stool
8.3.1.5. Urine
8.3.1.6. Blood
8.3.1.7. Tissues
8.3.1.8. Others
8.4. Middle East & Africa Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Diagnostic Laboratories
8.4.1.2. Microbiology Laboratories
8.4.1.3. Hospitals & Clinics
8.4.1.4. Others
8.5. Middle East & Africa Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. GCC Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
8.5.1.2. GCC Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
8.5.1.3. GCC Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
8.5.1.4. GCC Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
8.5.1.5. South Africa Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
8.5.1.6. South Africa Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
8.5.1.7. South Africa Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
8.5.1.8. South Africa Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
8.5.1.9. Egypt Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
8.5.1.10. Egypt Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
8.5.1.11. Egypt Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
8.5.1.12. Egypt Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
8.5.1.13. Nigeria Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
8.5.1.14. Nigeria Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
8.5.1.15. Nigeria Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
8.5.1.16. Nigeria Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
8.5.1.17. Rest of Middle East & Africa Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
8.5.1.18. Rest of Middle East & Africa Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
8.5.1.19. Rest of Middle East & Africa Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
8.5.1.20. Rest of Middle East & Africa Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Sample vs By Application Heatmap
9.2. Manufacturer vs By Application Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Thermo Fisher Scientific Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Becton, Dickinson, and Company
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Cardinal Health
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Quidel Corporation
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Medical Wire & Equipment
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. COPAN Diagnostics Inc.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Titan Biotech Ltd.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Alpha Teknova, Inc. [former named Teknova]
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Bio-Genex Laboratories Inc.
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. EKF Diagnostics
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

Thermo Fisher Scientific
Becton Dickinson and Company
Cardinal Health
Quidel Corporation
Medical Wire & Equipment (MWE)
COPAN Diagnostics Inc. [COPAN Group]
Titan Biotech Ltd.
Alpha Teknova, Inc. [formerly named Teknova]
Bio-Genex Laboratories Inc.
EKF Diagnostics
Trinity Biotech
Alpha-Tec Systems, Inc.
Charm Sciences, Inc.
Azer Scientific
bioBoaVista
AccuGene
KSL Diagnostics
Puritan Medical Products
Amazing Biotech (Shanghai) Co., Ltd.

Methodology

LOADING...